Level Chart

Basic Info

Eli Lilly & Co (LLY) - Oncology Revenue is at a current level of 1.884B, up from 1.747B last quarter and up from 1.651B one year ago. This is a change of 7.85% from last quarter and 14.12% from one year ago.

Oncology Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to oncology within a specific reporting period.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 1.884B
Latest Period Dec 2023
Last Updated Feb 29 2024, 08:53 EST
Next Release May 31 2024, 08:30 EDT (E)
Average Growth Rate 16.81%
Value from Last Quarter 1.747B
Change from Last Quarter 7.85%
Value from 1 Year Ago 1.651B
Change from 1 Year Ago 14.12%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
December 31, 2023 1.884B
September 30, 2023 1.747B
June 30, 2023 1.671B
March 31, 2023 1.356B
December 31, 2022 1.651B
September 30, 2022 1.293B
June 30, 2022 1.369B
March 31, 2022 1.353B
December 31, 2021 1.409B
Date Value
September 30, 2021 1.406B
June 30, 2021 1.554B
March 31, 2021 1.372B
December 31, 2020 1.516B
September 30, 2020 1.333B
June 30, 2020 1.269B
March 31, 2020 1.202B
December 31, 2019 1.080B

Basic Info

Eli Lilly & Co (LLY) - Oncology Revenue is at a current level of 1.884B, up from 1.747B last quarter and up from 1.651B one year ago. This is a change of 7.85% from last quarter and 14.12% from one year ago.

Oncology Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to oncology within a specific reporting period.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 1.884B
Latest Period Dec 2023
Last Updated Feb 29 2024, 08:53 EST
Next Release May 31 2024, 08:30 EDT (E)
Average Growth Rate 16.81%
Value from Last Quarter 1.747B
Change from Last Quarter 7.85%
Value from 1 Year Ago 1.651B
Change from 1 Year Ago 14.12%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
LLY Eli Lilly and Co -2.77%